CDT logo

Conduit Pharmaceuticals Inc. (CDT)

Profile

Full Name

Conduit Pharmaceuticals Inc.

Ticker

NASDAQ: CDT

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

March 28, 2022

Indexes

Not included

Website

https://www.conduitpharma.com

Employees

6

Key Details

Price

$0.80(-32.45%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$0.00(0.00% YoY)

Annual EPS

-$307.95(-342066.67% YoY)

PE ratio

-

Next earnings date

Nov 12, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $0.80
    CDT price is $0.80

    30-Day Relative Volume

    26.46
    CDT 30-day relative volume is 26.46

    Price Performance

    Price Most recent change

    -32.45%
    CDT price was down -32.45% on Sep 8, 2025

    Price YTD change

    -99.23%
    CDT price is down -99.23% since January 1st

    Price 1-year change

    -99.57%
    CDT price is down -99.57% year-on-year

    Price 3-year change

    -99.99%
    CDT price is down -99.99% over the past 3 years

    Price Range

    Price All-time high

    $37.50K
    CDT price is currently -100.00% below its historical high of $37.50 thousand

    Price 3-year low

    $0.78
    CDT price is currently +2.19% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $2.43M
    CDT market capitalization is $2.43 million

    Market cap 3-year change

    -98.27%
    CDT market capitalization is down -98.27% over the past 3 years

    Market cap All-time high

    $752.03M
    CDT market capitalization is currently -99.68% below its historical high of $752.03 million

    Market cap sector rank

    6.05%
    CDT market capitalization is higher than 6.05% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +4666.09%
    CDT shares outstanding is up +4666.09% year-on-year

    Shares Outstanding 3-Year Change

    +32698.92%
    CDT shares outstanding is up +32698.92% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    -0.55
    CDT beta is -0.55

    200-day SMA

    $34.98
    CDT price is currently -97.72% below its 200-day simple moving average

    50-day SMA

    $1.92
    CDT price is currently -58.41% below its 50-day simple moving average

    RSI

    16.85
    CDT 14-day relative strength index is 16.85

    Volume

    26.46
    CDT 30-day relative volume is 26.46

    ATR

    $0.15
    CDT average true range is $0.15

    10-day Historical Volatility

    160.77%
    CDT 10-day historical volatility is 160.77%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    CDT annual revenue is $0.00

    Revenue Analysts estimate

    -
    CDT annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    0%
    CDT annual revenue has remained unchanged year-on-year

    Revenue Sector rank

    28.79%
    CDT annual revenue is higher than 28.79% of companies in Healthcare sector

    EPS

    EPS

    -$307.95
    CDT annual earnings per share is -$307.95

    EPS Analysts estimate

    -
    CDT annual earnings per share consensus analysts' forecast is unknown

    EPS 1-year change

    -342066.67%
    CDT annual earnings per share is down -342066.67% year-on-year

    EPS Sector rank

    1.93%
    CDT annual earnings per share is higher than 1.93% of companies in Healthcare sector

    Profit

    Gross profit

    -$457.00K
    CDT annual gross profit is -$457.00 thousand

    Gross margin

    -
    CDT annual gross profit margin value is unknown

    Operating profit

    -$15.12M
    CDT annual operating income is -$15.12 million

    Operating margin

    -
    CDT annual operating profit margin value is unknown

    Net income

    -$17.80M
    CDT annual net profit is -$17.80 million

    Net margin

    -
    CDT annual net profit margin value is unknown

    Expenses

    Total expenses

    $15.12M
    CDT annual total expenses is $15.12 million

    Operating expenses

    $15.12M
    CDT annual total operating expenses is $15.12 million

    Cost of goods sold

    $457.00K
    CDT annual cost of goods sold is $457.00 thousand

    Selling, general & administrative expenses

    $12.04M
    CDT annual SGA is $12.04 million

    Depreciation and amortization

    $457.00K
    CDT annual depreciation & amortization is $457.00 thousand

    Interest expense

    $0.00
    CDT annual interest expense is $0.00

    Income tax

    $0.00
    CDT annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$16.31M
    CDT annual earnings before interest & taxes is -$16.31 million

    EBITDA

    -$15.85M
    CDT annual EBITDA is -$15.85 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $4.19M
    CDT annual total assets is $4.19 million

    Non current assets

    $1.48M
    CDT annual long term assets is $1.48 million

    Current assets

    $2.71M
    CDT annual total current assets is $2.71 million

    Cash and cash equivalents

    $554.00K
    CDT annual cash & cash equivalents is $554.00 thousand

    Accounts receivable

    -
    CDT annual accounts receivable value is unknown

    Inventory

    $0.00
    CDT annual inventory is $0.00

    Liabilities

    Total liabilities

    $10.99M
    CDT annual total liabilities is $10.99 million

    Long term liabilities

    $245.00K
    CDT annual total long term liabilities is $245.00 thousand

    Current liabilities

    $10.74M
    CDT annual total current liabilities is $10.74 million

    Accounts payable

    $1.43M
    CDT annual accounts payable is $1.43 million

    Debt

    Total debt

    $7.46M
    CDT annual total debt is $7.46 million

    Total debt 1-year change

    +657.06%
    CDT annual total debt is up +657.06% year-on-year

    Long term debt

    $107.00K
    CDT annual long term debt is $107.00 thousand

    Short term debt

    $7.35M
    CDT annual short term debt is $7.35 million

    Equity & Capital

    Shareholders equity

    -$6.79M
    CDT annual stockholders equity is -$6.79 million

    Book value

    -$6.79M
    CDT annual book value is -$6.79 million

    Retained earnings

    -$29.10M
    CDT annual retained earnings is -$29.10 million

    Working capital

    -$8.03M
    CDT annual working capital is -$8.03 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$9.68M
    CDT annual cash flow from operations is -$9.68 million

    Cash from operations 1-year change

    -25.33%
    CDT annual cash flow from operations is down -25.33% year-on-year

    Cash from investing

    -$43.00K
    CDT annual cash flow from investing activities is -$43.00 thousand

    Cash from investing 1-year change

    -105.93%
    CDT annual cash flow from investing activities is down -105.93% year-on-year

    Cash from financing

    $6.07M
    CDT annual cash flow from financing activities is $6.07 million

    Cash from financing 1-year change

    -44.49%
    CDT annual cash flow from financing activities is down -44.49% year-on-year

    CAPEX

    CAPEX

    $51.00K
    CDT annual capital expenditures is $51.00 thousand

    CAPEX 1-year change

    +100%
    CDT annual capital expenditures is up +100% year-on-year

    Free Cash Flow

    Free cash flow

    -$9.73M
    CDT annual free cash flow is -$9.73 million

    Free cash flow 1-year change

    -25.99%
    CDT annual free cash flow is down -25.99% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    CDT annual gross profit margin value is unknown

    Operating margin

    -
    CDT annual operating profit margin value is unknown

    Net margin

    -
    CDT annual net profit margin value is unknown

    ROA & ROE

    ROA

    -311.85%
    CDT annual return on assets is -311.85%

    ROE

    262.06%
    CDT annual return on equity is 262.06%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    CDT price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    CDT price to earnings ratio is unknown

    PB Ratio

    PB ratio

    0.69
    CDT price to book ratio is 0.69

    PB ratio Sector rank

    28.2%
    CDT price to book ratio is higher than 28.2% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    CDT price to sales ratio value is unknown

    PS ratio Sector rank

    -
    CDT price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $1.17M
    CDT enterprise value is $1.17 million

    Enterprise value Sector rank

    13.26%
    CDT enterprise value is higher than 13.26% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.07
    CDT EV/EBITDA is -0.07

    EV/EBITDA Sector rank

    61.86%
    CDT EV/EBITDA is higher than 61.86% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    0.25
    CDT annual current ratio is 0.25

    Quick ratio

    0.25
    CDT annual quick ratio is 0.25

    Leverage

    Debt to equity

    -1.10
    CDT annual debt to equity ratio is -1.10

    Interest coverage ratio

    -
    CDT annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    CDT piotroski f-score value is unknown

    Altman Z-Score

    -24.71
    CDT altman z-score is -24.71

    Analyst ratings

    Recent major analysts updates

    No data about analysts updates

    Institutional Ownership

    Screeners with CDT included

    Growing Shares Outstanding
    Stocks cheaper than 1 dollar
    US stocks
    Stocks below SMA 200
    NASDAQ Dividend Calendar
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Biotech Companies
    Ex Dividend dates calendar
    • What is the ticker symbol for Conduit Pharmaceuticals Inc.?
    • Does Conduit Pharmaceuticals Inc. pay dividends?
    • What sector is Conduit Pharmaceuticals Inc. in?
    • What industry is Conduit Pharmaceuticals Inc. in?
    • What country is Conduit Pharmaceuticals Inc. based in?
    • When did Conduit Pharmaceuticals Inc. go public?
    • Is Conduit Pharmaceuticals Inc. in the S&P 500?
    • Is Conduit Pharmaceuticals Inc. in the NASDAQ 100?
    • Is Conduit Pharmaceuticals Inc. in the Dow Jones?
    • When was Conduit Pharmaceuticals Inc.'s last earnings report?
    • When does Conduit Pharmaceuticals Inc. report earnings?

    What is the ticker symbol for Conduit Pharmaceuticals Inc.?

    The ticker symbol for Conduit Pharmaceuticals Inc. is NASDAQ:CDT

    Does Conduit Pharmaceuticals Inc. pay dividends?

    No, Conduit Pharmaceuticals Inc. does not pay dividends

    What sector is Conduit Pharmaceuticals Inc. in?

    Conduit Pharmaceuticals Inc. is in the Healthcare sector

    What industry is Conduit Pharmaceuticals Inc. in?

    Conduit Pharmaceuticals Inc. is in the Biotechnology industry

    What country is Conduit Pharmaceuticals Inc. based in?

    Conduit Pharmaceuticals Inc. is headquartered in United States

    When did Conduit Pharmaceuticals Inc. go public?

    Conduit Pharmaceuticals Inc.'s initial public offering (IPO) was on March 28, 2022

    Is Conduit Pharmaceuticals Inc. in the S&P 500?

    No, Conduit Pharmaceuticals Inc. is not included in the S&P 500 index

    Is Conduit Pharmaceuticals Inc. in the NASDAQ 100?

    No, Conduit Pharmaceuticals Inc. is not included in the NASDAQ 100 index

    Is Conduit Pharmaceuticals Inc. in the Dow Jones?

    No, Conduit Pharmaceuticals Inc. is not included in the Dow Jones index

    When was Conduit Pharmaceuticals Inc.'s last earnings report?

    Conduit Pharmaceuticals Inc.'s most recent earnings report was on August 14, 2025

    When does Conduit Pharmaceuticals Inc. report earnings?

    The next expected earnings date for Conduit Pharmaceuticals Inc. is November 12, 2025
    On this page